Literature DB >> 2506989

Treatment of shingles and post-herpetic neuralgia.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2506989      PMCID： PMC1837217          DOI： 10.1136/bmj.299.6695.392-c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Therapy of herpes zoster with oral acyclovir.

Authors:  J C Huff; B Bean; H H Balfour; O L Laskin; J D Connor; L Corey; Y J Bryson; P McGuirt
Journal:  Am J Med       Date:  1988-08-29       Impact factor: 4.965

Review 2.  Treatment of shingles and post-herpetic neuralgia.

Authors:  J V Jolleys
Journal:  BMJ       Date:  1989-06-10

3.  Antiviral treatment and postherpetic neuralgia.

Authors:  P Klenerman; T E Peto; G A Luzzi; B E Juel-Jensen
Journal:  BMJ       Date:  1989-03-25

4.  Lack of effect of acyclovir on postherpetic neuralgia.

Authors:  M W McKendrick; J I McGill; M J Wood
Journal:  BMJ       Date:  1989-02-18

5.  High-dose intravenous acyclovir in the treatment of zoster: a double-blind, placebo-controlled trial.

Authors:  B E Juel-Jensen; J A Khan; G Pasvol
Journal:  J Infect       Date:  1983-05       Impact factor: 6.072

6.  Efficacy of oral acyclovir treatment of acute herpes zoster.

Authors:  M J Wood; P H Ogan; M W McKendrick; C D Care; J I McGill; E M Webb
Journal:  Am J Med       Date:  1988-08-29       Impact factor: 4.965

7.  Severe herpes zoster infection in the United Kingdom: experience in a regional infectious disease unit.

Authors:  P Bannister; B Crosse
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

8.  Acyclovir therapy for acute herpes zoster.

Authors:  B Bean; C Braun; H H Balfour
Journal:  Lancet       Date:  1982-07-17       Impact factor: 79.321

9.  Prednisolone does not prevent post-herpetic neuralgia.

Authors:  V Esmann; J P Geil; S Kroon; H Fogh; N A Peterslund; C S Petersen; J O Ronne-Rasmussen; L Danielsen
Journal:  Lancet       Date:  1987-07-18       Impact factor: 79.321

10.  Intravenous acyclovir in acute herpes zoster infection.

Authors:  J McGill; D R MacDonald; C Fall; G D McKendrick; A Copplestone
Journal:  J Infect       Date:  1983-03       Impact factor: 6.072
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.